We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$18.7B
AUM Growth
+$1.89B
Cap. Flow
+$1.31B
Cap. Flow %
7.02%
Top 10 Hldgs %
10.01%
Holding
3,237
New
779
Increased
845
Reduced
690
Closed
834

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$109M
2
NCLH icon
Norwegian Cruise Line
NCLH
+$105M
3
GS icon
Goldman Sachs
GS
+$104M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$101M
5
STLD icon
Steel Dynamics
STLD
+$99.4M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$176M
2
KO icon
Coca-Cola
KO
+$151M
3
AVGO icon
Broadcom
AVGO
+$146M
4
MSFT icon
Microsoft
MSFT
+$140M
5
XOM icon
ExxonMobil
XOM
+$137M

Sector Composition

Rank Sector Weight
1 Technology 16.93%
2 Industrials 11.65%
3 Consumer Discretionary 11.56%
4 Healthcare 11.56%
5 Financials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARDC
1726
Are Dynamic Credit Allocation Fund
ARDC
$296M
$246K ﹤0.01%
21,211
– –
BUSE icon
1727
First Busey Corp
BUSE
$2.56B
$246K ﹤0.01%
9,943
-15,862
-61% -$397K
MNKD icon
1728
MannKind Corp
MNKD
$1.21B
$246K ﹤0.01%
46,639
+18,669
+67% +$76.4K
MASI
1729
DELISTED
Masimo
MASI
$243K ﹤0.01%
+1,644
New +$226K
FDBC icon
1730
Fidelity D&D Bancorp
FDBC
$308M
$242K ﹤0.01%
+5,142
New +$235K
ABCM
1731
DELISTED
Abcam PLC
ABCM
$241K ﹤0.01%
+15,513
New +$242K
SSB icon
1732
SouthState Bank Corp
SSB
$10.3B
$241K ﹤0.01%
+3,154
New +$265K
PBYI icon
1733
Puma Biotechnology
PBYI
$406M
$240K ﹤0.01%
56,628
+30,083
+113% +$104K
CLPT icon
1734
ClearPoint Neuro
CLPT
$436M
$239K ﹤0.01%
28,268
+12,657
+81% +$120K
ATNM icon
1735
Actinium Pharmaceuticals
ATNM
$27.2M
$239K ﹤0.01%
22,472
-683
-3% -$6.93K
BCAT icon
1736
BlackRock Capital Allocation Term Trust
BCAT
$1.62B
$239K ﹤0.01%
+17,207
New +$243K
EVBN
1737
DELISTED
Evans Bancorp Inc
EVBN
$239K ﹤0.01%
6,383
+542
+9% +$20.3K
RGR icon
1738
Sturm, Ruger & Co
RGR
$611M
$238K ﹤0.01%
+4,711
New +$256K
XPER icon
1739
Xperi
XPER
$368M
$238K ﹤0.01%
+27,672
New +$317K
EELV icon
1740
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$431M
$237K ﹤0.01%
10,279
-45,181
-81% -$1M
ESMT
1741
DELISTED
EngageSmart, Inc.
ESMT
$236K ﹤0.01%
+13,416
New +$246K
IAGG icon
1742
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
$235K ﹤0.01%
+4,950
New +$242K
SHYF
1743
DELISTED
The Shyft Group
SHYF
$235K ﹤0.01%
9,446
-20,050
-68% -$467K
KURA icon
1744
Kura Oncology
KURA
$826M
$234K ﹤0.01%
+18,887
New +$275K
ORIC icon
1745
Oric Pharmaceuticals
ORIC
$1.23B
$234K ﹤0.01%
39,688
+14,028
+55% +$47.4K
LPG icon
1746
Dorian LPG
LPG
$1.9B
$234K ﹤0.01%
+12,330
New +$221K
TCFC
1747
DELISTED
The Community Financial Corporation Common Stock
TCFC
$233K ﹤0.01%
+5,844
New +$225K
XHS icon
1748
State Street SPDR S&P Health Care Services ETF
XHS
$211M
$233K ﹤0.01%
2,747
+1,017
+59% +$89.4K
TOWN icon
1749
Towne Bank
TOWN
$3.53B
$233K ﹤0.01%
+7,549
New +$234K
CAL icon
1750
Caleres
CAL
$447M
$233K ﹤0.01%
+10,446
New +$256K
68 69
70
71 72

Similar funds

Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s Q4 2022 Portfolio in Review

As of Q4 2022, Qube Research & Technologies (QRT) held 3,237 positions worth $18.7B, up 11% from $16.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Qube Research & Technologies (QRT) deployed $1.31B of net new capital in Q4 2022, opening 779 new positions and adding to 845 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,451,017 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $140M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q4 2022 buy was Bristol-Myers Squibb: 1,451,017 shares worth $104M.
  • Qube Research & Technologies (QRT) added most to Goldman Sachs in Q4 2022, an estimated $104M increase.
  • Qube Research & Technologies (QRT)'s biggest Q4 2022 reduction was Microsoft, cutting an estimated $140M.
  • Qube Research & Technologies (QRT) fully exited Chevron in Q4 2022, selling an estimated $176M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $18.7B portfolio in Q4 2022.
  • Qube Research & Technologies (QRT) opened 779 new positions and closed 834 in Q4 2022.
  • Qube Research & Technologies (QRT)'s portfolio value rose 11% quarter-over-quarter to $18.7B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.